...
首页> 外文期刊>Pediatric transplantation. >Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation.
【24h】

Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation.

机译:小儿同种异体造血干细胞移植的准备条件期间和之后,增加的移植前QT分散性是发生心脏并发症的危险因素。

获取原文
获取原文并翻译 | 示例

摘要

Although cardiac complications are some of the most serious complications of HSCT for leukemia, it is difficult to predict them. QTD has been reported as a predictor of heart failure and fatal arrhythmia in adults. The purpose of this study is to examine whether QTD predicts cardiac complications in pediatric HSCT. Eighteen patients (mean age, 6.9 yr; 11 ALL and seven AML) underwent high-dose cyclophosphamide treatment and total body irradiation as preparative conditioning for HSCT. QTD, QTcD, echocardiographic functional parameters, and cumulative anthracycline dose were evaluated. We compared these values between patients with and without cardiac complications. Among 18 patients, seven patients experienced cardiac complications (heart failure in four, arrhythmia in three). There were significant differences in QTD (43.7 ms in patients with cardiac complications vs. 30.2 ms in patients without the complications, p = 0.019) and QTcD (55.3 vs. 36.9 ms, p = 0.003) between the two groups. On the other hand, the cumulative dose of anthracycline and echocardiographic parameters were not significantly different between the two groups. Increases in QTD and QTcD during the pretreatment period may be risk factors for the development of cardiac complications during and after conditioning for pediatric HSCT.
机译:尽管心脏并发症是白血病HSCT最严重的并发症之一,但难以预测。据报道,QTD可预测成人心力衰竭和致命性心律失常。这项研究的目的是检查QTD是否可预测小儿HSCT的心脏并发症。 18例患者(平均年龄6.9岁; 11例ALL和7例AML)接受了大剂量环磷酰胺治疗和全身放疗,作为HSCT的准备条件。评估了QTD,QTcD,超声心动图功能参数和蒽环类药物的累积剂量。我们比较了有和没有心脏并发症的患者之间的这些值。在18例患者中,有7例发生了心脏并发症(心衰4例,心律不齐3例)。两组之间的QTD(有心脏并发症的患者为43.7 ms,无并发症的患者为30.2 ms,p = 0.019)和QTcD有显着差异(55.3 vs. 36.9 ms,p = 0.003)。另一方面,两组间蒽环类药物的累积剂量和超声心动图参数无显着差异。预处理期间QTD和QTcD的升高可能是小儿HSCT适应期间和之后心脏并发症发生的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号